Somatic Mutations of the MEN1 Gene in Endocrine Tumors
Author Information
Author(s): Bergman L, Boothroyd C, Palmer J, Grimmond S, Walters M, Teh B, Shepherd J, Hartley L, Hayward N
Primary Institution: Queensland Cancer Fund Research Unit, Joint Experimental Oncology Programme of the Queensland Institute of Medical Research and the University of Queensland
Hypothesis
The study investigates the role of the MEN1 gene in sporadic endocrine tumorigenesis.
Conclusion
Inactivation of the MEN1 tumor suppressor gene contributes to the development of sporadic MEN1-type endocrine lesions.
Supporting Evidence
- Three primary parathyroid lesions and one pancreatic tumor were found to have lost one allele at the MEN1 locus.
- Somatic mutations were identified in one parathyroid lesion and in the glucagonoma.
Takeaway
The MEN1 gene can sometimes be broken in certain tumors, which helps explain how these tumors form.
Methodology
DNA from various primary and secondary endocrine tumors was analyzed for somatic MEN1 gene mutations and loss of heterozygosity.
Limitations
The study only included patients without a family history of MEN1.
Participant Demographics
Patients with sporadic endocrine tumors, none had a family history of MEN1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website